The Latest Breaking News from Family Dollar

Family Dollar says it is not aware of any complaints from customers nor any reports of illnesses related to the recall.

You would think discount stores would flourish in an era of high inflation and recession fears, but Dollar Tree (NASDAQ: DLTR) gapped down hard following its quarterly earnings report. Even so, the stock is outperforming the market, and its industry has been rallying. 

Dollar Tree Inc (NASDAQ:DLTR) reported first-quarter FY22 sales growth of 6.5% year-on-year to $6.90 billion, beating the consensus of $6.76 billion. Enterprise same-store sales increased 4.4%. Same-store sales for Dollar Tree increased 11.2%. Family Dollar same-store sales decreased 2.8%. Gross profit for the quarter rose 19.2% Y/Y to $2.34 billion, and the gross margin…

Multi-decade-high inflation and aggressive Fed rate increases might push the economy into a recession. So, investors looking to mitigate a market downturn should invest in Dollar Tree (DLTR) and Vertex Pharmaceuticals (VRTX), as they could deliver stable returns because their businesses enjoy a near-inelastic demand.

Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector, with the goal of determining which company is the better investment.

Eli Lilly and Albemarle lead five stocks that have shown resilience amid the sell-off and may be poised to lead the way forward.

Dollar Tree is Stock of the Day. The discounter is flirting with an aggressive buying opportunity. But it could flash a sell signal too.

More than 1,000 rodents were unconvered after the distribution facility was fumigated last winter

Arkansas is suing Family Dollar over the discovery of 1,000 rodents in a distribution facility in the state that prompted the discount retail chain to recall items purchased from hundreds of stores in the South